![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/07/15/2913378/0/en/Organogenesis-Holdings-Inc-to-Report-Second-Quarter-of-Fiscal-Year-2024-Financial-Results-on-August-8-2024.html
https://www.globenewswire.com/news-release/2024/06/06/2895051/0/en/Organogenesis-Holdings-Inc-to-Participate-in-the-Truist-Securities-MedTech-Conference.html
https://www.globenewswire.com/news-release/2024/05/09/2879178/0/en/Organogenesis-Holdings-Inc-Reports-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/02/2874026/0/en/Organogenesis-Achieves-Primary-Endpoint-in-Phase-3-Clinical-Trial-of-ReNu-for-Knee-Osteoarthritis.html
https://www.globenewswire.com/news-release/2024/04/16/2863491/0/en/Organogenesis-Holdings-Inc-to-Report-First-Quarter-of-Fiscal-Year-2024-Financial-Results-on-May-9-2024.html
https://www.globenewswire.com/news-release/2024/04/03/2856820/0/en/Organogenesis-Announces-Favorable-Court-Ruling-Dismissing-Securities-Fraud-Case.html
https://www.globenewswire.com//news-release/2023/10/05/2755275/0/en/Organogenesis-Holdings-Inc-to-Report-Third-Quarter-of-Fiscal-Year-2023-Financial-Results-on-November-9-2023.html
https://www.globenewswire.com//news-release/2023/09/28/2751308/0/en/Organogenesis-Applauds-Withdrawal-of-Local-Coverage-Determinations-by-Novitas-First-Coast-Service-Options-and-CGS.html
https://www.globenewswire.com//news-release/2023/09/06/2738846/0/en/Organogenesis-Holdings-Inc-to-Participate-in-the-Morgan-Stanley-21st-Annual-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2023/08/09/2722100/0/en/Organogenesis-Holdings-Inc-Reports-Second-Quarter-2023-Financial-Results-Withdraws-Fiscal-Year-2023-Guidance.html